ATXS Similar Chart Price Prediction
The price of ATXS is predicted to go up 58.09%, based on the high correlation periods with OWLT. The similarity of these two price pattern on the periods is 98.22%.
ATXS
OWLT
Up: 58.09%Similarity: 98.22%
ATXS Revenue Forecast
ATXS EPS Forecast
ATXS Analyst's Forecast
Jonathan Wolleben
JMP Securities
Buy
2025-01-31
Price Target
$26
Upside
+238.1%
JMP Securities analyst Jonathan Wolleben initiated coverage of Astria Therapeutics with an Outperform rating and $26 price target. Astria is using its half-life extension technology to develop long-acting mAbs targeting "de-risked targets in large, proven markets," the analyst tells investors in a research note. The firm says the company's lead candidate, navenibart, which is starting Phase 3 testing to prevent hereditary angioedema attacks, is addressing a "proven, blockbuster market." JMP says navenibart has a de-risked mechanism with extended durability.
Hartaj Singh
Oppenheimer
Buy
2024-11-14
Price Target
$26 → $28
Upside
+168.97%
